International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Cited by (1,054)

Items 1,001–1,054 of 1,054

1. Purified IgG from Patients with Obstetric but not IgG from Non‐obstetric Antiphospholipid Syndrome Inhibit Trophoblast Invasion
   Katie Poulton, Vera M. Ripoll, Charis Pericleous, Pier Luigi Meroni, Maria Gerosa, Yiannis Ioannou, Anisur Rahman, Ian Giles · 2014 · American Journal of Reproductive Immunology
2. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (<scp>APS</scp>) in the <scp>APS</scp> Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study
   de Jesús, GR, Sciascia, S, Andrade, D, Barbhaiya, M, Tektonidou, M, Banzato, A, Pengo, V, Ji, L, Meroni, PL, Ugarte, A et al. · 2019 · BJOG: An International Journal of Obstetrics &amp; Gynaecology
3. Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies
   Tortosa, Carlos, Cabrera-Marante, Oscar, Serrano, Manuel, Martínez-Flores, José A., Pérez, Dolores, Lora, David, Morillas, Luis, Paz-Artal, Estela, Morales, José M., Pleguezuelo, Daniel et al. · 2017 · PLoS ONE
4. Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases
   SWADŹBA, J., IWANIEC, T., SZCZEKLIK, A., MUSIAŁ, J. · 2007 · Journal of Thrombosis and Haemostasis
5. No more mixing tests required for integrated assay systems in the laboratory diagnosis of lupus anticoagulants?
   DEVREESE, K.M.J. · 2010 · Journal of Thrombosis and Haemostasis
6. IgA antiphospholipid antibodies are an independent risk factor for thromboses
   Shen, YM, Lee, R, Frenkel, E, Sarode, R · 2008 · Lupus
7. Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus
   Demir, Selcan, Li, Jessica, Magder, Laurence S, Petri, Michelle · 2021 · Rheumatology
8. The Pathogenicity of Anti-<i>β</i>2GP1-IgG Autoantibodies Depends on Fc Glycosylation
   Fickentscher, Christoph, Magorivska, Iryna, Janko, Christina, Biermann, Mona, Bilyy, Rostyslav, Nalli, Cecilia, Tincani, Angela, Medeghini, Veronica, Meini, Antonella, Nimmerjahn, Falk et al. · 2015 · Journal of Immunology Research
9. Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage
   van den Boogaard, Emmy, Cohn, Danny M., Korevaar, Johanna C., Dawood, Feroza, Vissenberg, Rosa, Middeldorp, Saskia, Goddijn, Mariette, Farquharson, Roy G. · 2013 · Fertility and Sterility
10. Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE
    Domingues, Vinicius, Magder, Laurence S, Petri, Michelle · 2016 · Lupus Science &amp; Medicine
11. Clinical Relevance of Isolated Lupus Anticoagulant Positivity in Patients with Thrombotic Antiphospholipid Syndrome
    Yin, Dongmei, de Groot, Philip G., Ninivaggi, Marisa, Devreese, Katrien M. J., de Laat, Bas · 2021 · Thrombosis and Haemostasis
12. Variability of cut‐off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study
    Tripodi, A., Chantarangkul, V., Cini, M., Devreese, K., Dlott, J. S, Giacomello, R., Gray, E., Legnani, C., Martinuzzo, M.E., Pradella, P. et al. · 2017 · Journal of Thrombosis and Haemostasis
13. From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: Pathogenic mechanisms of the antiphospholipid syndrome
    Du, Vivian X., Kelchtermans, Hilde, de Groot, Philip G., de Laat, Bas · 2013 · Thrombosis Research
14. Dilute Russell's viper venom time reagents in lupus anticoagulant testing: a well‐considered choice
    Depreter, Barbara, Devreese, Katrien M.J. · 2017 · Clinical Chemistry and Laboratory Medicine (CCLM)
15. Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification
    Vanoverschelde, Laura, Kelchtermans, Hilde, Musial, Jacek, de Laat, Bas, Devreese, Katrien M.J. · 2019 · Research and Practice in Thrombosis and Haemostasis
16. Clinical relevance of multiple antibody specificity testing in anti-phospholipid syndrome and recurrent pregnancy loss
    Tebo, A E, Jaskowski, T D, Hill, H R, Branch, D W · 2008 · Clinical and Experimental Immunology
17. Anticardiolipin and anti-β2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays
    Devreese, Katrien M.J., Van Hoecke, Frederik · 2011 · Thrombosis Research
18. Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio
    Amory, Colum F., Levine, Steven R., Brey, Robin L., Gebregziabher, Mulugeta, Tuhrim, Stanley, Tilley, Barbara C., Simpson, Ann-Catherin C., Sacco, Ralph L., Mohr, Jay P., for the APASS-WARSS Collaborators · 2015 · Cerebrovascular Diseases
19. Comparison of therapeutic interventions for recurrent pregnancy loss in association with antiphospholipid syndrome: A systematic review and network meta‐analysis
    Liu, Xiang, Qiu, Yuxuan, Yu, Esther Dawen, Xiang, Shang, Meng, Rui, Niu, Kai fan, Zhu, Huili · 2020 · American Journal of Reproductive Immunology
20. Extended persistence of antiphospholipid antibodies beyond the 12‐week time interval: association with baseline antiphospholipid antibodies titres
    Devignes, Jean, Smaïl‐Tabbone, Malika, Hervé, Alex, Cagninacci, Geoffroy, Devignes, Marie‐Dominique, Lecompte, Thomas, Zuily, Stéphane, Wahl, Denis · 2019 · International Journal of Laboratory Hematology
21. Lupus anticoagulant detection: out of control?
    Moore, G. W., Brown, K. L., Bromidge, E. S., Drew, A. J., Ledford‐Kraemer, M. R. · 2013 · International Journal of Laboratory Hematology
22. Lupus anticoagulant mixing tests for multiple reagents are more sensitive if interpreted with a mixing test‐specific cut‐off than index of circulating anticoagulant
    Kumano, Osamu, Moore, Gary W. · 2018 · Research and Practice in Thrombosis and Haemostasis
23. Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays
    Pradella, Paola, Azzarini, Gabriella, Santarossa, Liliana, Caberlotto, Livio, Bardin, Cristina, Poz, Alessandra, D’Aurizio, Federica, Giacomello, Roberta · 2013 · Clinical Chemistry and Laboratory Medicine (CCLM)
24. Identification of Mitofusin 1 and Complement Component 1q Subcomponent Binding Protein as Mitochondrial Targets in Systemic Lupus Erythematosus
    Becker, Yann L. C., Gagné, Jean‐Philippe, Julien, Anne‐Sophie, Lévesque, Tania, Allaeys, Isabelle, Gougeard, Nadine, Rubio, Vicente, Boisvert, François‐Michel, Jean, Dominique, Wagner, Eric et al. · 2022 · Arthritis &amp; Rheumatology
25. Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant
    Posch, Florian, Gebhart, Johanna, Rand, Jacob H., Koder, Silvia, Quehenberger, Peter, Pengo, Vittorio, Ay, Cihan, Pabinger, Ingrid · 2017 · BMC Medicine
26. Ruling out lupus anticoagulants with mixing test-specific cutoff assessment and the index of circulating anticoagulant
    Kumano, Osamu, Moore, Gary W. · 2019 · Research and Practice in Thrombosis and Haemostasis
27. Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma
    Lackner, K.J., Müller‐Calleja, N. · 2016 · Journal of Thrombosis and Haemostasis
28. Antiphospholipid antibody profile stability over time: prospective results from the APS ACTION clinical database and repository
    Gkrouzman, Elena, Sevim, Ecem, Finik, Jackie, Andrade, Danieli, Pengo, Vittorio, Sciascia, Savino, Tektonidou, Maria G., Ugarte, Amaia, Chighizola, Cecilia B., Belmont, H. Michael et al. · 2021 · The Journal of Rheumatology
29. Antiphospholipid syndrome: an update for clinicians and scientists
    Vreede, Andrew P., Bockenstedt, Paula L., Knight, Jason S. · 2017 · Current Opinion in Rheumatology
30. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant
    Hong, Sung Kuk., Hwang, Sang Mee., Kim, Ji-Eun, Kim, Hyun Kyung · 2012 · Blood Coagulation &amp; Fibrinolysis
31. Single or triple positivity for antiphospholipid antibodies in “carriers” or symptomatic patients: Untangling the knot
    Bertin, Daniel, Camoin‐Jau, Laurence, Veit, Véronique, Resseguier, Noémie, Lambert, Mathilde, Buffet Delmas, Pauline, Heim, Xavier, Mège, Jean‐Louis, Morange, Pierre‐Emmanuel, Bardin, Nathalie · 2021 · Journal of Thrombosis and Haemostasis
32. Enoxaparin and aspirin therapy for recurrent pregnancy loss due to anti-phospholipid syndrome (APS)
    Mohamed, Khalid Abd Aziz, Saad, Ahmed Samy · 2014 · Middle East Fertility Society Journal
33. Comparison and evaluation of different methodologies and tests for detection of anti-dsDNA antibodies on 889 Slovenian patients' and blood donors' sera
    Žigon, Polona, Lakota, Katja, Čučnik, Saša, Švec, Tinka, Ambrožič, Aleš, Sodin-Šemrl, Snežna, Kveder, Tanja · 2011 · Croatian Medical Journal
34. Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti‐beta2 glycoprotein‐1 antibodies
    Fontana, P., Poncet, A., Lindhoff‐Last, E., de Moerloose, P., Devreese, K.M. · 2014 · Journal of Thrombosis and Haemostasis
35. Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion
    Zen, Margherita, Loredo Martinez, Marta, Benvenuti, Francesco, Gatto, Mariele, Saccon, Francesca, Larosa, Maddalena, Iaccarino, Luca, Doria, Andrea · 2021 · Rheumatology
36. Lupus anticoagulant assay cut‐offs vary between reagents even when derived from a common set of normal donor plasmas
    Moore, Gary W., Kumano, Osamu · 2020 · Journal of Thrombosis and Haemostasis
37. Association of autoantibodies to heat‐shock protein 60 with arterial vascular events in patients with antiphospholipid antibodies
    Dieudé, Mélanie, Correa, José A., Neville, Carolyn, Pineau, Christian, Levine, Jerrold S., Subang, Rebecca, Landolt‐Marticorena, Carolina, Su, Jiandong, Kassis, Jeannine, Solymoss, Susan et al. · 2011 · Arthritis &amp; Rheumatism
38. Anti-cardiolipin and anti-β2-glycoprotein I antibodies: normal reference ranges in northwestern Italy
    Montaruli, B, De Luna, E, Mengozzi, G, Molinari, F, Napolitano, E, Napoli, P, Nicolo, C, Romito, A, Stella, S, Bazzan, M et al. · 2012 · Lupus
39. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test
    Kumano, Osamu, Ieko, Masahiro, Naito, Sumiyoshi, Yoshida, Mika, Takahashi, Nobuhiko, Suzuki, Takeshi, Aoki, Takashi · 2014 · Thrombosis Research
40. Lupus anticoagulant testing – sometimes mixing is required: potential for false negatives without mixing studies
    Favaloro, Emmanuel J., Bonar, Roslyn, Marsden, Katherine · 2013 · Blood Coagulation &amp; Fibrinolysis
41. Diagnostic Challenges on the Laboratory Detection of Lupus Anticoagulant
    Tripodi, Armando · 2021 · Biomedicines
42. Evaluation of an automated algorithm for interpretation of lupus anticoagulant testing
    Florin, Lisa, Desloovere, Maxime, Devreese, Katrien M. J. · 2019 · International Journal of Laboratory Hematology
43. Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome
    Becker, Yann LC, Julien, Anne-Sophie, Godbout, Alexandra, Boilard, Éric, Fortin, Paul R · 2020 · Lupus
44. Improvements in diagnosis and risk assessment of primary and secondary antiphospholipid syndrome
    Petri, Michelle · 2019 · Hematology
45. Lupus Anticoagulant Detection under the Magnifying Glass
    Molinari, Angelo Claudio, Martini, Tiziano, Banov, Laura, Ierardi, Antonella, Leotta, Marzia, Strangio, Alessandra, Santoro, Rita Carlotta · 2023 · Journal of Clinical Medicine
46. Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies Carriers
    Zuo, Yu, Fan, Jennifer, Sarode, Ravi, Zhang, Song, Makris, Una E., Karp, David R., Shen, Yu-Min · 2018 · Clinical and Applied Thrombosis/Hemostasis
47. Insights into the 2023 ACR/EULAR antiphospholipid syndrome classification criteria: findings from a cohort of 205 patients with primary APS
    Zen, Margherita, Tonello, Marta, Carta, Francesco, Calligaro, Antonia, Favaro, Maria, Del Ross, Teresa, Hulej, Greta, Rahmé, Zahrà, Ruffatti, Amelia, Doria, Andrea · 2025 · Rheumatology
48. Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus
    Petri, Michelle A, Avci, Mertcan, Magder, Laurence S · 2020 · Lupus Science &amp; Medicine
49. Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay
    Moore, Gary W., Foxton, Eleanor, Platton, Sean, Yartey, Nada, White, Danielle, MacDonald, Stephen G. · 2023 · Journal of Thrombosis and Haemostasis
50. Lupus anticoagulant test persistence over time and its associations with future thrombotic events
    Colling, Meaghan E., Ay, Cihan, Kraemmer, Daniel, Koder, Silvia, Quehenberger, Peter, Pabinger, Ingrid, Posch, Florian, Gebhart, Johanna · 2022 · Blood Advances
51. Viewpoint: Lupus anticoagulant detection and interpretation in antiphospholipid syndrome
    Efthymiou, Maria, Bertolaccini, Maria Laura, Cohen, Hannah · 2024 · Rheumatology
52. Comparison of different algorithms for lupus anticoagulant detection: a single-center experience
    Apipongrat, Dollapak, Lamool, Rattapan, Arnutti, Pasra, Ruangpratheep, Chetana, Chantkran, Wittawat · 2024 · Research and Practice in Thrombosis and Haemostasis
53. Lupus Anticoagulant Testing in Challenging Situations: Navigating Complexities
    Devreese, Katrien M. J. · 2026 · International Journal of Laboratory Hematology
54. Hydroxychloroquine as an Adjunct Therapy for Secondary Thrombosis Prevention in Primary Antiphospholipid Syndrome: A Systematic Review and Meta-analysis
    de Carvalho, Jozélio Freire, Hautz, Elizabeth, Cervera, Ricard · 2026 · Rheumatology and Therapy